RADAR – issue #1 – July 2024
This issue of RADAR provides an overview of medicines recently revised on the Pharmaceutical Benefits Scheme (PBS) including:
- Nirmatrelvir and ritonavir (Paxlovid®) and molnupiravir (Lagevrio®) for COVID-19 (amended PBS listing)
- Type 2 diabetes mellitus (T2DM) medicines (amended PBS restrictions).
Learn more about RADAR.
Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.
For more information
Publication year
2024
Resource type
Newsletter